Scoop: Tur­ing CEO and Shkre­li al­ly Ron Tilles is out as CEO, R&D chief Sali­nas takes the helm and board vote looms

Regime change of some sort is un­der­way at the con­tro­ver­sial Tur­ing Phar­ma­ceu­ti­cals.

Tipped off on Fri­day that CEO and co-founder Ron Tilles — a close as­so­ciate …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER